189 related articles for article (PubMed ID: 30651005)
1. The Impact of Lifestyle Modification on Cardiometabolic Risk Factors in Health-Care Employees With Type 2 Diabetes.
Das S; Rouseff M; Guzman HE; Osondu CU; Brown D; Betancourt B; Ochoa T; Mora J; Lehn V; Sherriff SB; Rubens MB; Saxena A; Nasir K; Veledar E
Am J Health Promot; 2019 Jun; 33(5):745-748. PubMed ID: 30651005
[TBL] [Abstract][Full Text] [Related]
2. One-year outcomes of an intense workplace cardio-metabolic risk reduction program among high-risk employees: The My Unlimited Potential.
Rouseff M; Aneni EC; Guzman H; Das S; Brown D; Osondu CU; Spatz E; Shaffer B; Santiago-Charles J; Ochoa T; Mora J; Gilliam C; Lehn V; Sherriff S; Tran TH; Post J; Veledar E; Feldman T; Agatston AS; Nasir K
Obesity (Silver Spring); 2016 Jan; 24(1):71-8. PubMed ID: 26637983
[TBL] [Abstract][Full Text] [Related]
3. Effect of a Workplace Wellness Program on Employee Health and Economic Outcomes: A Randomized Clinical Trial.
Song Z; Baicker K
JAMA; 2019 Apr; 321(15):1491-1501. PubMed ID: 30990549
[TBL] [Abstract][Full Text] [Related]
4. The Effectiveness of a Worksite Lifestyle Intervention Program on High-Risk Individuals as Potential Candidates for Bariatric Surgery: My Unlimited Potential (MyUP).
Osondu CU; Aneni EC; Shaharyar S; Roberson L; Rouseff M; Das S; Spatz E; Younus A; Guzman H; Brown D; Santiago-Charles J; Ochoa T; Mora J; Gilliam C; Lehn V; Sherriff S; Tran T; Gonzalez A; Virani S; Feldman T; Agatston AS; Nasir K
Popul Health Manag; 2016 Oct; 19(5):368-75. PubMed ID: 26760281
[TBL] [Abstract][Full Text] [Related]
5. Lifestyle intervention reduces body weight and improves cardiometabolic risk factors in worksites.
Salinardi TC; Batra P; Roberts SB; Urban LE; Robinson LM; Pittas AG; Lichtenstein AH; Deckersbach T; Saltzman E; Das SK
Am J Clin Nutr; 2013 Apr; 97(4):667-76. PubMed ID: 23426035
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a multicomponent workplace health promotion program conducted in Japan for improving employees' cardiovascular disease risk factors.
Muto T; Yamauchi K
Prev Med; 2001 Dec; 33(6):571-7. PubMed ID: 11716652
[TBL] [Abstract][Full Text] [Related]
7. Worksite Opportunities for Wellness (WOW): effects on cardiovascular disease risk factors after 1 year.
Racette SB; Deusinger SS; Inman CL; Burlis TL; Highstein GR; Buskirk TD; Steger-May K; Peterson LR
Prev Med; 2009; 49(2-3):108-14. PubMed ID: 19576927
[TBL] [Abstract][Full Text] [Related]
8. Combined diet and exercise intervention in the workplace: effect on cardiovascular disease risk factors.
White K; Jacques PH
AAOHN J; 2007 Mar; 55(3):109-14. PubMed ID: 17405587
[TBL] [Abstract][Full Text] [Related]
9. Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight.
John EJ; Vavra T; Farris K; Currie J; Doucette W; Button-Neumann B; Osterhaus M; Kumbera P; Halterman T; Bullock T
Pharmacotherapy; 2006 Oct; 26(10):1511-7. PubMed ID: 16999661
[TBL] [Abstract][Full Text] [Related]
10. Effects of a Workplace Wellness Program on Employee Health, Health Beliefs, and Medical Use: A Randomized Clinical Trial.
Reif J; Chan D; Jones D; Payne L; Molitor D
JAMA Intern Med; 2020 Jul; 180(7):952-960. PubMed ID: 32453346
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the Baptist Employee Healthy Heart Study: a randomized trial assessing the efficacy of the addition of an interactive, personalized, web-based, lifestyle intervention tool to an existing health information web platform in a high-risk employee population.
Post JM; Ali SS; Roberson LL; Aneni EC; Shaharyar S; Younus A; Jamal O; Ahmad R; Aziz MA; Malik R; Spatz ES; Feldman T; Fialkow J; Veledar E; Cury RC; Agatston AS; Nasir K
Trials; 2016 Jul; 17(1):308. PubMed ID: 27369488
[TBL] [Abstract][Full Text] [Related]
12. Ferrari Corporate Wellness Program: Results of a Pilot Analysis and the "Drag" Impact in the Workplace.
Biffi A; Fernando F; Adami PE; Messina M; Sirico F; Di Paolo F; Coluccia R; Borghi C; D'Ascenzi F; Volpe M
High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):261-266. PubMed ID: 29956111
[TBL] [Abstract][Full Text] [Related]
13. Financial Incentives and Diabetes Disease Control in Employees: A Retrospective Cohort Analysis.
Misra-Hebert AD; Hu B; Taksler G; Zimmerman R; Rothberg MB
J Gen Intern Med; 2016 Aug; 31(8):871-7. PubMed ID: 27067350
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of a corporate exercise intervention programme on cardiovascular risk profile, fitness and productivity: A South African view.
Torres G; Fouche J; Redelinghuys R; Brussow B; Cronson D; Zanuso S; Constantinou D
S Afr Med J; 2020 Sep; 110(10):1045-1049. PubMed ID: 33205737
[TBL] [Abstract][Full Text] [Related]
15. Improvements in Cardiometabolic Risk Factors Among Overweight and Obese Employees Participating in a University Worksite Wellness Program.
Radler DR; Marcus AF; Griehs R; Touger-Decker R
Health Promot Pract; 2015 Nov; 16(6):805-13. PubMed ID: 25384579
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the Well at Dell health management program: health risk change and financial return on investment.
Musich S; McCalister T; Wang S; Hawkins K
Am J Health Promot; 2015; 29(3):147-57. PubMed ID: 25559251
[TBL] [Abstract][Full Text] [Related]
17. Assessing and targeting key lifestyle cardiovascular risk factors at the workplace: Effect on hemoglobin A1c levels.
Lévesque V; Poirier P; Després JP; Alméras N
Ann Med; 2015; 47(7):605-14. PubMed ID: 26542534
[TBL] [Abstract][Full Text] [Related]
18. Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs.
Milani RV; Lavie CJ
Am J Cardiol; 2009 Nov; 104(10):1389-92. PubMed ID: 19892055
[TBL] [Abstract][Full Text] [Related]
19. 'Prosiect Sir Gâr': workplace-based cardiovascular disease and diabetes risk assessments.
Gray BJ; Bracken RM; Thomas M; Williams SP; Williams M; Rice S; Stephens JW;
Occup Med (Lond); 2014 Oct; 64(7):549-56. PubMed ID: 25194014
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus.
Salinero-Fort MA; Carrillo-de Santa Pau E; Arrieta-Blanco FJ; Abanades-Herranz JC; Martín-Madrazo C; Rodés-Soldevila B; de Burgos-Lunar C
BMC Public Health; 2011 Apr; 11():267. PubMed ID: 21524316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
